BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Leo A, Calderon A, Lieberman PM. Control of Viral Latency by Episome Maintenance Proteins. Trends Microbiol 2020;28:150-62. [PMID: 31624007 DOI: 10.1016/j.tim.2019.09.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Susana Borkosky S, Fassolari M, Campos-león K, Hugo Rossi A, Salgueiro M, Antonela Pascuale C, Peralta Martínez R, Gaston K, de Prat Gay G. Biomolecular condensation of the human papillomavirus E2 master regulator with p53: Implications in viral replication. Journal of Molecular Biology 2022. [DOI: 10.1016/j.jmb.2022.167889] [Reference Citation Analysis]
2 Ding W, Wang C, Narita Y, Wang H, Leong MML, Huang A, Liao Y, Liu X, Okuno Y, Kimura H, Gewurz B, Teng M, Jin S, Sato Y, Zhao B. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines. J Virol 2022;:e0073922. [PMID: 36094314 DOI: 10.1128/jvi.00739-22] [Reference Citation Analysis]
3 Lin Y, Valle-inclan JE, Mazzagatti A, Hu Q, Maurais EG, Guyer A, Sanders JT, Engel J, Nguyen G, Bronder D, Bakhoum SF, Cortés-ciriano I, Ly P. Mitotic clustering of pulverized chromosomes from micronuclei.. [DOI: 10.1101/2022.07.19.500697] [Reference Citation Analysis]
4 Paganelli R. Resurrecting Epstein–Barr Virus. Pathogens 2022;11:772. [DOI: 10.3390/pathogens11070772] [Reference Citation Analysis]
5 Gupta A, Owens SM, Oldenburg DG, White DW, Forrest JC. Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo. J Virol 2022;:e0069022. [PMID: 35647668 DOI: 10.1128/jvi.00690-22] [Reference Citation Analysis]
6 Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies. Viruses 2022;14:1017. [DOI: 10.3390/v14051017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Caruso LB, Guo R, Keith K, Madzo J, Maestri D, Boyle S, Wasserman J, Kossenkov A, Gewurz BE, Tempera I. The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. PLoS Pathog 2022;18:e1010400. [PMID: 35421198 DOI: 10.1371/journal.ppat.1010400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dheekollu J, Wiedmer A, Soldan SS, Castro Muñoz LJ, Tang H, Speicher DW, Lieberman PM. Regulation of EBNA1 Protein Stability by PLOD1 Lysine Hydroxylase.. [DOI: 10.1101/2022.03.29.486189] [Reference Citation Analysis]
9 Lagadec F, Parissi V, Lesbats P. Targeting the Nucleosome Acidic Patch by Viral Proteins: Two Birds with One Stone? mBio 2022;:e0173321. [PMID: 35343785 DOI: 10.1128/mbio.01733-21] [Reference Citation Analysis]
10 Borkosky SS, Fassolari M, Campos-león K, Rossi AH, Salgueiro M, Pascuale C, Martínez RP, Gaston K, de Prat Gay G. The guardian of the genome meets a viral master gene regulator at a biomolecular condensate.. [DOI: 10.1101/2022.02.09.479752] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yuan L, Li S, Chen Q, Xia T, Luo D, Li L, Liu S, Guo S, Liu L, Du C, Jia G, Li X, Lu Z, Yang Z, Liu H, Mai H, Tang L. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ 2022. [PMID: 35105963 DOI: 10.1038/s41418-022-00939-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Niemeyer BF, Sanford B, Gibson JE, Berger JN, Oko LM, Medina E, Clambey ET, van Dyk LF. The gammaherpesvirus 68 viral cyclin facilitates expression of LANA. PLoS Pathog 2021;17:e1010019. [PMID: 34780571 DOI: 10.1371/journal.ppat.1010019] [Reference Citation Analysis]
13 Gam Ze Letova C, Kalt I, Shamay M, Sarid R. Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV. Int J Mol Sci 2021;22:11994. [PMID: 34769420 DOI: 10.3390/ijms222111994] [Reference Citation Analysis]
14 Tempera I, Lieberman PM. Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Front Virol 2021;1:753366. [PMID: 35141704 DOI: 10.3389/fviro.2021.753366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J, Li R. Caspases Switch off the m6A RNA Modification Pathway to Foster the Replication of a Ubiquitous Human Tumor Virus. mBio 2021;12:e0170621. [PMID: 34425696 DOI: 10.1128/mBio.01706-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Caruso LB, Guo R, Keith K, Madzo J, Maestri D, Boyle S, Wasserman J, Kossenkov A, Gewurz BE, Tempera I. The Nuclear Lamina Binds the EBV Genome During Latency and Regulates Viral Gene Expression.. [DOI: 10.1101/2021.08.05.455214] [Reference Citation Analysis]
17 Gaglia MM. Kaposi's sarcoma-associated herpesvirus at 27. Tumour Virus Res 2021;12:200223. [PMID: 34153523 DOI: 10.1016/j.tvr.2021.200223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jones SE. Papillomaviruses in equids: A decade of discovery and more to come? Equine Veterinary Education 2022;34:236-40. [DOI: 10.1111/eve.13506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Soldan SS, Anderson EM, Frase DM, Zhang Y, Caruso LB, Wang Y, Deakyne JS, Gewurz BE, Tempera I, Lieberman PM, Messick TE. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer. Gastric Cancer 2021;24:1076-88. [PMID: 33929613 DOI: 10.1007/s10120-021-01193-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
20 Friedenson B. In BRCA1 and BRCA2 breast cancers, chromosome breaks occur near herpes tumor virus sequences.. [DOI: 10.1101/2021.04.19.440499] [Reference Citation Analysis]
21 Richardson BE. Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study. Ann Otol Rhinol Laryngol 2021;130:1383-91. [PMID: 33834883 DOI: 10.1177/00034894211007227] [Reference Citation Analysis]
22 Diggins NL, Crawford LB, Hancock MH, Mitchell J, Nelson JA. Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34+ Hematopoietic Progenitor Cell Proliferation To Maintain the Latent Viral Genome. mBio 2021;12:e00621-21. [PMID: 33824207 DOI: 10.1128/mBio.00621-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Abboodi F, Delva NC, Emmel J, Renrick A, Buckhaults P, Banister CE, Creek KE, Pirisi L. Human papillomavirus-mediated carcinogenesis and tumor progression. GENOME INSTAB DIS 2021;2:71-91. [DOI: 10.1007/s42764-021-00038-x] [Reference Citation Analysis]
24 Majumder K, Morales AJ. Utilization of Host Cell Chromosome Conformation by Viral Pathogens: Knowing When to Hold and When to Fold. Front Immunol 2021;12:633762. [PMID: 33841414 DOI: 10.3389/fimmu.2021.633762] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Jan Fada B, Reward E, Gu H. The Role of ND10 Nuclear Bodies in Herpesvirus Infection: A Frenemy for the Virus? Viruses 2021;13:239. [PMID: 33546431 DOI: 10.3390/v13020239] [Reference Citation Analysis]
26 Cohen JI. Herpesvirus latency. J Clin Invest 2020;130:3361-9. [PMID: 32364538 DOI: 10.1172/JCI136225] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 43.0] [Reference Citation Analysis]
27 Lamontagne RJ, Soldan SS, Su C, Wiedmer A, Won KJ, Lu F, Goldman AR, Wickramasinghe J, Tang HY, Speicher DW, Showe L, Kossenkov AV, Lieberman PM. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. PLoS Pathog 2021;17:e1009208. [PMID: 33497421 DOI: 10.1371/journal.ppat.1009208] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
28 Dheekollu J, Wiedmer A, Ayyanathan K, Deakyne JS, Messick TE, Lieberman PM. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance. Cell 2021;184:643-654.e13. [PMID: 33482082 DOI: 10.1016/j.cell.2020.12.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
29 Liu X, Hong T, Parameswaran S, Ernst K, Marazzi I, Weirauch MT, Fuxman Bass JI. Human Virus Transcriptional Regulators. Cell 2020;182:24-37. [PMID: 32649876 DOI: 10.1016/j.cell.2020.06.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
30 Vladimirova O, De Leo A, Deng Z, Wiedmer A, Hayden J, Lieberman PM. Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation. PLoS Pathog 2021;17:e1009231. [PMID: 33471863 DOI: 10.1371/journal.ppat.1009231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
31 Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, Narita Y, Zhang Z, Olson MR, Afzali B, Zhao B, Kazemian M. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. J Virol 2020;94:e01390-20. [PMID: 32999023 DOI: 10.1128/JVI.01390-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
32 Calderon A, Soldan SS, De Leo A, Deng Z, Frase DM, Anderson EM, Zhang Y, Vladimirova O, Lu F, Leung JC, Murphy ME, Lieberman PM. Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism. Oncotarget 2020;11:4224-42. [PMID: 33245718 DOI: 10.18632/oncotarget.27815] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J, Li R. Caspases switch off m6A RNA modification pathway to reactivate a ubiquitous human tumor virus.. [DOI: 10.1101/2020.11.12.377127] [Reference Citation Analysis]
34 Mauch-Mücke K, Schön K, Paulus C, Nevels MM. Evidence for Tethering of Human Cytomegalovirus Genomes to Host Chromosomes. Front Cell Infect Microbiol 2020;10:577428. [PMID: 33117732 DOI: 10.3389/fcimb.2020.577428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Groves IJ, Sinclair JH, Wills MR. Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off? Front Cell Infect Microbiol 2020;10:329. [PMID: 32714883 DOI: 10.3389/fcimb.2020.00329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Hau PM, Lung HL, Wu M, Tsang CM, Wong KL, Mak NK, Lo KW. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma. Front Oncol 2020;10:600. [PMID: 32528868 DOI: 10.3389/fonc.2020.00600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
37 Messick TE, Tolvinski L, Zartler ER, Moberg A, Frostell Å, Smith GR, Reitz AB, Lieberman PM. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. Molecules 2020;25:E1760. [PMID: 32290261 DOI: 10.3390/molecules25071760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Buschle A, Hammerschmidt W. Epigenetic lifestyle of Epstein-Barr virus. Semin Immunopathol 2020;42:131-42. [PMID: 32232535 DOI: 10.1007/s00281-020-00792-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
39 [DOI: 10.1101/2020.05.15.097808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]